Infectious Disease
RSSArticles
-
Dialysis: Overcoming Resistance and Reducing Infections
The Centers for Disease Control and Prevention estimates some 40,000 central line-associated bloodstream infections occur annually in U.S. hemodialysis patients. -
IPs Respond to CMS Legionella Directive
Primarily caused by Legionella pneumophila serogroup 1, Legionnaires' Disease outbreaks in healthcare are typically traced to the waterborne bug becoming aerosolized and inhaled in shower mist. -
CDC Detects 221 Bugs with Unusual Drug Resistance
The Centers for Disease Control and Prevention is using its nationwide Antibiotic Resistance Lab Network to detect these virtually untreatable bugs, which can be resistant to whole classes of drugs. -
CDC to CRE: You Cannot Pass
A national containment strategy using powerful lab detection techniques and rapid intervention with infection control measures is blunting the emergence of pan-resistant pathogens, the Centers for Disease Control and Prevention reports. -
Clinical Briefs
In this section: treating obstructive sleep apnea; influenza and myocardial infarction; and a promising Zika treatment.
-
Tildrakizumab-asmn Injection (Ilumya)
Tildrakizumab-asmn is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
-
Pre-existing Health Determines Quality of Life, Physical Symptoms After ICU Discharge
The authors of this nested cohort study within a randomized, controlled trial of ICU survivors requiring > 48 hours of mechanical ventilation found that pre-existing comorbidity was the main determinant of long-term health-related quality of life.
-
Hospital Ice Machines Contaminated With Bacteria
Requiring staff to cleanse their hands with alcohol hand gel prior to using an ice machine and directing housekeeping personnel to perform more frequent machine cleaning may improve situation.
-
Mefloquine: Still Effective and Still Safe for Malaria Chemoprophylaxis
Mefloquine is known as an effective agent for malaria chemoprophylaxis. However, concerns about serious adverse effects have limited its use. Now, a careful review of data suggests that fatal outcomes related to mefloquine prophylaxis are very rare.
-
Infectious Disease Alert Updates
Probiotics and Lactobacillemia; The Last Poliovirus Challenge